Sera Prognostics Financials
| SERA Stock | USD 7.44 0.70 10.39% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.21 | 2.5097 |
|
|
The essential information of the day-to-day investment outlook for Sera Prognostics includes many different criteria found on its balance sheet. An individual investor should monitor Sera Prognostics' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Sera Prognostics.
Net Income |
|
Sera | Select Account or Indicator |
Understanding current and past Sera Prognostics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sera Prognostics' financial statements are interrelated, with each one affecting the others. For example, an increase in Sera Prognostics' assets may result in an increase in income on the income statement.
Please note, the presentation of Sera Prognostics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sera Prognostics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sera Prognostics' management manipulating its earnings.
Sera Prognostics Stock Summary
Sera Prognostics competes with Unicycive Therapeutics, Hoth Therapeutics, and Instil Bio. Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Sera Prognostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US81749D1072 |
| CUSIP | 81749D107 |
| Location | Utah; U.S.A |
| Business Address | 2749 East Parleys |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | seraprognostics.com |
| Phone | 801 990 0520 |
| Currency | USD - US Dollar |
Sera Prognostics Key Financial Ratios
| Return On Equity | -0.5 | ||||
| Operating Margin | (305.59) % | ||||
| Price To Sales | 2,422 X | ||||
| Revenue | 306 K | ||||
| Gross Profit | 75 K |
Sera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sera Prognostics's current stock value. Our valuation model uses many indicators to compare Sera Prognostics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sera Prognostics competition to find correlations between indicators driving Sera Prognostics's intrinsic value. More Info.Sera Prognostics is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At present, Sera Prognostics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sera Prognostics' earnings, one of the primary drivers of an investment's value.Sera Prognostics Systematic Risk
Sera Prognostics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sera Prognostics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Sera Prognostics correlated with the market. If Beta is less than 0 Sera Prognostics generally moves in the opposite direction as compared to the market. If Sera Prognostics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sera Prognostics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sera Prognostics is generally in the same direction as the market. If Beta > 1 Sera Prognostics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Sera Prognostics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sera Prognostics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sera Prognostics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Sera Prognostics November 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sera Prognostics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sera Prognostics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sera Prognostics based on widely used predictive technical indicators. In general, we focus on analyzing Sera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sera Prognostics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 27.67 | |||
| Value At Risk | (7.61) | |||
| Potential Upside | 9.17 |
Complementary Tools for Sera Stock analysis
When running Sera Prognostics' price analysis, check to measure Sera Prognostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sera Prognostics is operating at the current time. Most of Sera Prognostics' value examination focuses on studying past and present price action to predict the probability of Sera Prognostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sera Prognostics' price. Additionally, you may evaluate how the addition of Sera Prognostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |